Shirly Grynberg, MD, is an oncology specialist in the Ella Lemelbaum Institute of Immuno-Oncology at Sheba Medical Center, Israel. She received her first degree in basic science at 2007 and her medical degree in 2015  at Tel Aviv University, Israel. Since receiving her board certification in Medical Oncology she focuses on clinical diagnosis, management and treatment of melanoma and skin cancer patients, acts as a principal and sub investigator in phase I-III clinical trials.